UNITOV

University of Rome Tor Vergata

In Italy, the HERVCOV project will be conducted at the Laboratories of Microbiology and Clinical Microbiology at the Department of Experimental Medicine of the University of Rome Tor Vergata (UNITOV) authorized and equipped for handling biohazard specimens, and supervised by Prof. Claudia Matteucci. By means of multiple methodological approaches, the feasibility of the HERVCOV project will be ensured by the expertise of an interdisciplinary team of experts in microbiology, immunology and infectious diseases, and the equipment of the laboratories involved. The research activity aimed at the characterization of the role of HERVs in the crosstalk with the inflammatory response in complex diseases. Moreover, UNITOV partner has contributed with several studies in the field of molecular and cellular mechanisms underlying the action of immunomodulating, antitumor and antiviral molecules. Based on the experience of the SARS-CoV-2 infection pandemic, the research objectives are aimed at ex-vivo evaluation from blood of acute and long COVID-19 patients, to characterize the immune-dysregulation associated with cytokine storm, and the identification of early markers of SARS-CoV-2 infection with diagnostic and prognostic potential, such as CD169 and Human Endogenous Retroviruses (HERVs) expression (Balestrieri et al, 2021; Minutolo et al, 2021). The University of Rome Tor Vergata was established in 1982 and is therefore a relatively young University. It was designed on the model of Anglo-Saxon campuses: it stretches on 600 hectares and hosts important research institutions, such as National Research Council – CNR and the Italian Space Agency – ASI. Furthermore, the Campus hosts one of the most modern hospitals in Italy, i.e. Policlinico Tor Vergata hospital, a care and research centre which is a reference point for the whole Lazio region and where our Medical School is active as well. The mission of the University of Rome Tor Vergata is to contribute to people’s education and training, to scientific research and to the technological, organizational and social innovation needed to achieve a truly sustainable development in Italy, Europe and worldwide pursuant to the Sustainable Development Goals approved by the United Nations in September 2015.
 University of Rome Tor Vergata https://en.uniroma2.it/ 
Department of Experimental Medicine https://medsper.uniroma2.it/

Team

MATTEUCCI

Claudia Matteucci

Ph.D, Professor (Associate) at University of Rome Tor Vergata
Rome, Italy
Principal Investigator for UNITOV, Claudia Matteucci currently works at the Department of Experimental
Medicine of the University of Rome Tor Vergata. As associate professor, Claudia is teacher of Microbiology
and Clinical Microbiology. Claudia does research in Microbiology, Cancer and Immunology. Her current
research is mainly focused on Endogenous retroviruses physiopathology and host-microbe interaction.
Skills: Apoptosis Assays, Cell Culture, Flow Cytometry, Biological Tumor Markers, HTLV-I Infections,
NF-kappa B, Endogenous Retroviruses, Combination Drug Therapy, Experimental Melanoma Protein
Expression, Thymosin, Immune Response, Cancer Stem Cell, Biology, Microbiology, Apoptosis, Peripheral
Blood Mononuclear Cell, Cancer Biology, Immunophenotyping, COVID-19

Research info

Social

antonella

Antonella Minutolo

PhD, Professor (Assistant) at University of Rome Tor Vergata
Skills: Apoptosis, Cell Cycle, Immune Response, HIV, Endogenous Retroviruses, COVID-19, Evaluation of
functional immune modulation processes and analysis of host immunological changes in infectious diseases. Flow
cytometry, Array analysis, Macrovesicles’, miRNAs, natural compounds, immune adjuvants, antivirals.

Research info

Social

BALESTRIERI

Emanuela Balestrieri

PhD, Professor (Associate) at University of Rome Tor Vergata, Italy

Skills: Endogenous Retroviruses, Autism Spectrum Disorders, COVID-19, Peripheral Blood Mononuclear

Cells, HTLV-1 Infection, Antiretrovirals, Molecular and Cell Biology, Cancer Biology, Microbiology.

Research info

Social

Vita Petrone

PhD, Post Doc researcher at University of Rome Tor Vergata, Italy
Skills: Cancer Stem Cells, Cell Culture, Cancer Biology, Gene Transcription, Flow Cytometry, Apoptosis,
Cell Proliferation, Tumor Microenvironment, Cell Migration, RNA, Regulation of Gene Expression, Cancer
Immunology, Cell Cycle Analysis, Cell InvasionTumor, Angiogenesis, Cell Line Culture, Peripheral Blood
Mononuclear Cell, Microvesicles, PCR

Research info

FANELLI

Marialaura Fanelli

Bachelor of Science PhD Student at University of Rome Tor Vergata, Italy
Skills: Cancer Immunology,Regulation of Gene Expression,Cell Cycle, Flow Cytometry,Apoptosis,Cell
Proliferation,Tumor Microenvironment, plant miRNAs, Microvesicles,Peripheral Blood Mononuclear
Cell,Gene Expression, RNA Extraction

Research info

GRELLI

Sandro Grelli

MD, Professor (Associate) at University of Rome Tor Vergata, Virology Unit of Tor Vergata Hospital , Italy
Skills: Peripheral Blood Mononuclear Cell, Immunology, Natural Killer Cells, Flow Cytometry, Cell
Culture, Immunity, Immunology of Infectious Diseases, Immunomodulation, Cytokine, Biology, Viral
Immunology

Research info

SARMATI

Loredana Sarmati

M.D. Full Professor at University of Rome Tor Vergata, Infectious Disease Unit of Tor Vergata Hospital,
Italy
Skills: Tuberculosis, HIV, Immunology, Vaccine, Microbiology, Hepatitis B, Infectious Diseases, Hepatitis
C, AIDS Prevention, Immunology of Infectious Diseases, Lymphocytes, Listeria, Epidemiology, STD
Immunity

Research info

Social

IANNETTA

Marco Iannetta

MD, PhD Professor (Associate), at University of Rome Tor Vergata Infectious Diseases Unit of Tor Vergata Hospital, Italy
Skills: HIV Immunology, AIDS, Multicolor Flow Cytometry, Dendritic Cell Biology, T-Lymphocyte
Immune Activation, Progressive Multifocal Leukoencephalopathy and JCPyV, Immunology of Infectious
Diseases, Antimicrobial Resistance, Arboviruses

Research info

Social

BERNARDINI

Sergio Bernardini

MD, Professor (Full), at University of Rome Tor Vergata, Clinical Biochemistry and Clinical Molecular
Biochemistry of Tor Vergata Hospital

Research info